EUVIMEDEUVIMED entdecken
Open Access

Development of new thiosemicarbazones with strong α-glucosidase and antioxidant action

Memona Kamal, Nastaran Sadeghian, Feyzi Sinan Tokalı iD, Mostafa A Ismail, Parham Taslimi, Rima D Alharthy, Asif Rasool, Orhan Ulucay, Halil Şenol iD, Zahid Shafiq iD

Future Medicinal Chemistry · 2026

DOI: 10.1080/17568919.2026.2675874 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Medicinal Chemistry, 2026. Verfasst von Memona Kamal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan. Hauptthemen laut MEDLINE: Thiosemicarbazones, Antioxidants, Glycoside Hydrolase Inhibitors, alpha-Glucosidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Deanship of Research and Graduate Studies at King Khalid University, Saudi Arabi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIM: This study aimed to synthesize a new series of thiosemicarbazone derivatives (4a-r) as multifunctional antidiabetic candidates with dual α-glucosidase (α-Glu) inhibitory and antioxidant activities to address both hyperglycemia and oxidative stress in diabetes management. MATERIALS AND METHODS: Compounds were synthesized and characterized spectroscopically. The in vitro studies were done on compounds for α-Glu inhibitory and metal-chelating properties. The docking studies and MM-GBSA experimental analyses were implemented for the evaluation of binding strength, coupled with 500 ns molecular dynamics in order to validate the stability of the enzyme-ligand complex. ADME prediction tools were employed to evaluate pharmacokinetic suitability. RESULTS: Compound 4d (p-methylbenzyl) showing the strongest α-Glu inhibition (IC50 = 206.91 nM, Ki = 235.86 nM), significantly surpassing acarbose. Additionally, 4d demonstrated the most effective antioxidant activity (IC50 = 26.85 µg/mL). Computational findings confirmed its favorable binding free energy (-82.36 kcal/mol) and stable interactions with catalytic residues throughout the MD simulations. ADME predictions indicated good intestinal permeability and 89% oral absorption, suggesting improved pharmacokinetic behavior. CONCLUSION: Compound 4d emerges as a highly promising dual-function antidiabetic candidate with strong enzymatic inhibition, effective antioxidant action, and desirable drug-like features, making it a valuable lead for future optimization and further biological evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThiosemicarbazonesAntioxidantsGlycoside Hydrolase Inhibitorsalpha-GlucosidasesHypoglycemic AgentsMolecular Docking SimulationHumansStructure-Activity RelationshipMolecular Dynamics SimulationMolecular StructureBiphenyl Compounds

Stichwörter der Autor:innen

Aryl sulfonateantioxidantdiabetes mellitusmolecular dynamicsthiosemicarbazone

Substanzen

ThiosemicarbazonesAntioxidantsGlycoside Hydrolase Inhibitorsalpha-GlucosidasesHypoglycemic AgentsBiphenyl Compounds

Autor:innen und Institutionen

  • Institute of Chemical Sciences, Bahauddin Zakariya University, Multan, Pakistan.
  • Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Türkiye.
  • Department of Material and Material Processing Technologies, Kars Vocational School, Kafkas University, Kars, Türkiye.
  • Research Center for Advanced Materials Science (RCAMS), Chemistry Department, Faculty of Science, King Khalid University, Abha, Saudi Arabia.
  • Department of Chemistry, Science & Arts College, Rabigh Branch, King Abdulaziz University, Rabigh, Saudi Arabia.
  • School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, Jiangsu, China.

ORCID-Profile: Feyzi Sinan Tokalı, Halil Şenol, Zahid Shafiq

Förderung

  • Deanship of Research and Graduate Studies at King Khalid University, Saudi Arabi

Zitieren

APA

Kamal, M., Sadeghian, N., Tokalı, F. S., Ismail, M. A., Taslimi, P., Alharthy, R. D., Rasool, A., Ulucay, O., Şenol, H., & Shafiq, Z. (2026). Development of new thiosemicarbazones with strong α-glucosidase and antioxidant action. Future Medicinal Chemistry. https://doi.org/10.1080/17568919.2026.2675874

Vancouver

Kamal M, Sadeghian N, Tokalı FS, Ismail MA, Taslimi P, Alharthy RD, et al. Development of new thiosemicarbazones with strong α-glucosidase and antioxidant action. Future Medicinal Chemistry. 2026. doi:10.1080/17568919.2026.2675874

BibTeX
@article{Kamal2026,
  author = {Kamal, Memona and Sadeghian, Nastaran and Tokalı, Feyzi Sinan and Ismail, Mostafa A and Taslimi, Parham and Alharthy, Rima D and Rasool, Asif and Ulucay, Orhan and Şenol, Halil and Shafiq, Zahid},
  title = {Development of new thiosemicarbazones with strong α-glucosidase and antioxidant action},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  doi = {10.1080/17568919.2026.2675874}
}
Kostenlos starten →